MedPath
NMPA Approval

Levamlodipine Besylate Tablets

国药准字H20249815

December 25, 2024

Drug Information

苯磺酸左氨氯地平片

片剂

5mg(按C₂₀H₂₅ClN₂O₅计)

化学药品

December 25, 2024

Company Information

Applicant Company

四川省德阳市广汉市台北路西二段8号

Manufacturing Company

四川省德阳市广汉市台北路西二段8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

苯磺酸左氨氯地平片 - NMPA 批准文号 | MedPath